Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Double Blind, Placebo-Controlled, Randomized, Multicentric, Study to Evaluate the Efficacy and Safety of PreCrea®, a Twice-daily Dietary Supplement in People With Higher Than Normal Blood Sugar Levels.

NCT02189005 is registered in ClinicalTrials.gov with Joe Fenn as lead sponsor.

NCT NCT02189005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02189005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Double Blind, Placebo-Controlled, Randomized, Multicentric, Study to Evaluate the Efficacy and Safety of PreCrea®, a Twice-daily Dietary Supplement in People With Higher Than Normal Blood Sugar Levels.
Lead sponsor
Joe Fenn
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2013
Completion date
November 30, 2014
Enrollment
210 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, hyperglycemia, metabolic syndrome, pre-diabetes